SPRB

Spruce Biosciences, Inc.

SPRB · CIK 1683553 · Annual (10-K) · Last 5 years

Financial Trends

Revenue$5M
20202024
Net Income−$53M
20202024
Operating CF−$56M
20202024
Free Cash Flow−$56M
20202024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.0B$0.0B———
Cost of Revenue—————
Gross Profit—————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense—————
Operating Income$-0.1B$-0.1B$-0.0B$-0.0B$-0.0B
Net Income$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-1.29$-1.24$-1.96——
EPS (Diluted)$-1.29$-1.24$-1.96——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.0B$0.1B$0.1B$0.1B$0.2B
Current Assets$0.0B$0.1B$0.1B$0.1B$0.2B
Cash & Equivalents$0.0B$0.1B$0.0B$0.0B$0.2B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.1B$0.1B$0.1B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.1B$0.0B$-0.1B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$0.0B$-0.0B$0.0B$0.2B
← Companies